Market Overview:
The global hydroxychloroquine sulphate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of autoimmune diseases, rising awareness about hydroxychloroquine sulphate, and growing demand for generic drugs. However, the high cost of branded drugs may restrain the growth of this market during the forecast period. Based on type, the global hydroxychloroquine sulphate market is segmented into 100mg, 200mg, and others. The 200mg segment is expected to account for a major share of this market in 2018 owing to its higher efficacy in treating autoimmune diseases as compared to other dosages. Based on application, this market is segmented into lupus erythematosus (LE), rheumatoid arthritis (RA), and others. RA is estimated to be the largest application segment in 2018 owing to its high prevalence across all regions worldwide. Geographically, North America dominates this global hydroxychloroquine sulphate market followed by Europe.
Product Definition:
Hydroxychloroquine sulphate is a long-acting, anti-inflammatory agent used to treat malaria and rheumatoid arthritis. It is also effective in the treatment of lupus erythematosus and other autoimmune diseases. Hydroxychloroquine sulphate stabilizes cell membranes, preventing the release of histamine and other mediators of inflammation.
100mg:
Hydroxychloroquine Sulphate, also known as hydroxychloroquine, is an immunosuppressive drug with anti-viral properties. It's used to treat a variety of viral infections such as malaria and auto-immune diseases like lupus and rheumatoid arthritis.
200mg:
200mg is used for the treatment of viral diseases like malaria, yellow fever, and dengue. 200 mg of hydroxychloroquine sulfate is also used in the treatment of lupus erythematosus and rheumatoid arthritis. It works by killing bacteria that are responsible for causing infections in body tissues.
Application Insights:
The others segment dominated the global market in terms of revenue share in 2017. This is due to the presence of applications such as lupus erythematosus, rheumatoid arthritis and others. Lupus erythematosus was estimated as the largest segment owing to its high prevalence globally coupled with increasing awareness about OTC availability for treatment purposes.
Rheumatoid arthritis is another major application driving growth globally owing to its rising incidence and awareness programs undertaken by public & private organizations, local authorities and healthcare professionals for diagnostics & treatment facilities at an domestic level coupled with a growing aging population susceptible to this condition who can benefit from OTC drugs. These factors are projected to drive demand over the forecast period thus impacting overall market growth negatively.
Regional Analysis:
North America was the leading revenue contributor in 2017. The region is anticipated to maintain its dominance over the forecast period, with the U.S. being a key contributor to market growth.
In Asia Pacific, Japan is estimated to be one of the major contributors owing to high disease prevalence coupled with increased government spending on healthcare research & development activities aimed at developing novel drugs for treatment of autoimmune diseases such as lupus.
The Middle East & Africa (MEA) market is projected to grow at a lucrative rate over the coming years due rising awareness about early diagnosis.
Growth Factors:
- Increasing prevalence of autoimmune diseases: Hydroxychloroquine sulphate is used for the treatment of a wide range of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and Sjögren's syndrome. The global prevalence of autoimmune diseases is increasing, which is expected to drive the demand for hydroxychloroquine sulphate in the coming years.
- Rising awareness about hydroxychloroquine sulphate: There is a growing awareness among healthcare professionals and patients about the benefits of hydroxychloroquine sulphate therapy. This is likely to boost demand for this drug in the coming years.
- Growing use of combination therapies: Hydroxychloroquine sulphate is often used in combination with other drugs for better efficacy and tolerability. The growing use of combination therapies will fuel demand for this drug in the near future.
- Technological advancements: The development of new formulations and delivery systemsof hydroxychloroquine sulfatesuch as oral tablets, subcutaneous injections, and intramuscular injections will help widen its scopeof usein various indicationsand boost itsdemandin themarketplaceoverthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxychloroquine Sulphate Market Research Report
By Type
100mg, 200mg, Others
By Application
Lupus Erythematosus, Rheumatoid Arthritis, Others
By Companies
Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxychloroquine Sulphate Market Report Segments:
The global Hydroxychloroquine Sulphate market is segmented on the basis of:
Types
100mg, 200mg, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lupus Erythematosus, Rheumatoid Arthritis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Novartis
- Shanghai Zhongxisanwei
- Teva
- Zydus Cadila
- Mylan
- Apotex
- Advanz Pharma
- Sun Pharma
- Kyung Poong
- Ipca Laboratories
- Hanlim Pharmaceutical
- Bristol Laboratories
Highlights of The Hydroxychloroquine Sulphate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 100mg
- 200mg
- Others
- By Application:
- Lupus Erythematosus
- Rheumatoid Arthritis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxychloroquine Sulphate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxychloroquine Sulphate is a medication used to treat malaria. It works by stopping the growth of the parasite in your body.
Some of the major companies in the hydroxychloroquine sulphate market are Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxychloroquine Sulphate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxychloroquine Sulphate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxychloroquine Sulphate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxychloroquine Sulphate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxychloroquine Sulphate Market Size & Forecast, 2020-2028
4.5.1 Hydroxychloroquine Sulphate Market Size and Y-o-Y Growth
4.5.2 Hydroxychloroquine Sulphate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 100mg
5.2.2 200mg
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Lupus Erythematosus
6.2.2 Rheumatoid Arthritis
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxychloroquine Sulphate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxychloroquine Sulphate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 100mg
9.6.2 200mg
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Lupus Erythematosus
9.10.2 Rheumatoid Arthritis
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 100mg
10.6.2 200mg
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Lupus Erythematosus
10.10.2 Rheumatoid Arthritis
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 100mg
11.6.2 200mg
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Lupus Erythematosus
11.10.2 Rheumatoid Arthritis
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 100mg
12.6.2 200mg
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Lupus Erythematosus
12.10.2 Rheumatoid Arthritis
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 100mg
13.6.2 200mg
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Lupus Erythematosus
13.10.2 Rheumatoid Arthritis
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxychloroquine Sulphate Market: Competitive Dashboard
14.2 Global Hydroxychloroquine Sulphate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Novartis
14.3.3 Shanghai Zhongxisanwei
14.3.4 Teva
14.3.5 Zydus Cadila
14.3.6 Mylan
14.3.7 Apotex
14.3.8 Advanz Pharma
14.3.9 Sun Pharma
14.3.10 Kyung Poong
14.3.11 Ipca Laboratories
14.3.12 Hanlim Pharmaceutical
14.3.13 Bristol Laboratories
